Professor Kim Youngwoo and his team from Kumoh National Institute of Technology have achieved a significant milestone by having their research paper selected for ‘Early Accept’ at MICCAI 2026, a prestigious medical AI conference. Their study, which stands out among the top 9% globally, introduces an innovative AI model that combines MRI and clinical data to identify high-risk polycystic kidney disease patients non-invasively. The model, validated with data from 414 patients across eight U.S. hospitals, surpasses traditional methods that rely solely on imaging or clinical data. This research is particularly important for regions where genetic testing is expensive or inaccessible, offering a promising tool for early patient risk stratification. Professor Kim emphasizes the potential of integrating imaging and clinical data to improve healthcare access and plans to continue advancing medical imaging AI research. Supported by the National Research Foundation of Korea and the Korea Health Industry Development Institute, this achievement underscores the global research capabilities of regional universities.
How did Professor Kim Youngwoo’s team achieve ‘Early Accept’ at MICCAI 2026?
